Pharma R&D Today

Using Reaxys for Lead Optimization: A Case Study

Posted on November 13th, 2015 by Thibault Geoui

Epigen Biosciences is a start-up pharmaceutical company that collaborates with academic groups to discover innovative drugs for a range of medical conditions, including renal diseases, cancer and CNS disorders. Co-founder Dr. Fabio Tucci met with Elsevier to discuss how Epigen researchers use Reaxys to support their application of advanced hit-to-lead and lead optimization methods. (more…)